Validation of a weight-based nomogram for the use of intravenous heparin in transient ischemic attack or stroke

被引:21
|
作者
Toth, C [1 ]
Voll, C [1 ]
机构
[1] Univ Saskatchewan, Royal Univ Hosp, Dept Med, Div Neurol, Saskatoon, SK S7N 0W8, Canada
关键词
heparin; ischemic attack; transient; nomogram; stroke;
D O I
10.1161/hs0302.104168
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and Purpose-Intravenous heparin therapy is often used in patients presenting with transient ischemic attack (TIA) or stroke as either bridging therapy for anticoagulation with warfarin or primary therapy in suspected intracranial arterial dissection, crescendo TIAs, or suspected hypercoagulable states. We attempted to validate the use or a weight-based nomogram for heparin-adjusted therapy during hospital admission of patients with TIA or stroke. Methods-A prospective, single-blinded, randomized, clinical trial was undertaken to compare the use of a specially designed, weight-based heparin nomogram against the traditional method of physician-ordered heparin therapy for patients admitted with TIA or stroke. The trial was not designed to examine the efficacy of heparin therapy but to examine the use of the nomogram for labor requirements, costs of monitoring, safety, length or heparin therapy, and user-friendliness. Results-Pretreatment clinical factors were comparable between those randomized to use of the nomogram (n = 101) and to usual care (n = 105). Nomogram patients had a significantly lower first activated partial thromboplastin time than nonnomogram patients (60.6 +/- 16.8 versus 69.8 +/- 28.7 seconds). Patients treated by nomogram achieved a therapeutic range of anticoagulation sooner than nonnomogram patients (13.4 +/- 17.0 versus 17.9 +/- 14.1 hours). The fraction of time during which anticoagulation was therapeutic was significantly greater in patients on nomogram therapy (74 +/- 25% versus 67 +/- 26%). Nomogram patients also had significantly fewer supratherapeutic coagulation results, significantly fewer dose adjustment mistakes, significantly fewer calls to house staff regarding anticoagulation, and significantly fewer total complications than nonnomogram patients. The times required for discontinuation of heparin and discharge from hospital were not significantly different. A survey of house staff and nursing staff showed a preference for nomogram use. Conclusions-The heparin nomogram is a user-friendly method of maintaining heparin infusions and is associated with improved anticoagulation measures, fewer total complications related to heparin therapy, fewer mistakes in heparin dosage adjustment, and decreased labor on the part of house staff and nursing staff.
引用
收藏
页码:670 / 674
页数:5
相关论文
共 50 条
  • [41] Effect of body weight on bleeding events of aspirin in ischemic stroke or transient ischemic attack patients
    Wang, Xiaoyu
    Zhu, Qidong
    Wu, Yan
    Li, Huiting
    Deng, Xiaomei
    Cheng, Juan
    Zhang, Zhetao
    Ma, Yini
    Shi, Tianlu
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2022, 47 (10) : 1684 - 1689
  • [42] Validation and unification of a score to predict stroke risk after transient ischemic attack
    Johnston, S.
    Rothwell, Peter M.
    Nguyen-Huynh, Mai
    Giles, Matthew F.
    Elkins, Jacob
    Sidney, Stephen
    NEUROLOGY, 2007, 68 (12) : A193 - A194
  • [43] Validation of CSR model to predict stroke risk after transient ischemic attack
    Zhao, Lu
    Cao, Shuang
    Pei, Lulu
    Fang, Hui
    Liu, Hao
    Wu, Jun
    Sun, Shilei
    Gao, Yuan
    Song, Bo
    Xu, Yuming
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [44] Validation of CSR model to predict stroke risk after transient ischemic attack
    Lu Zhao
    Shuang Cao
    Lulu Pei
    Hui Fang
    Hao Liu
    Jun Wu
    Shilei Sun
    Yuan Gao
    Bo Song
    Yuming Xu
    Scientific Reports, 12
  • [45] Assessment of Migraine History in Patients with a Transient Ischemic Attack or Stroke; Validation of a Migraine Screener for Stroke
    van der Willik, Daphne
    Pelzer, Nadine
    Algra, Ale
    Terwindt, Gisela M.
    Wermer, Marieke J. H.
    EUROPEAN NEUROLOGY, 2017, 77 (1-2) : 16 - 22
  • [46] Pioglitazone after Ischemic Stroke or Transient Ischemic Attack
    Kernan, W. N.
    Viscoli, C. M.
    Furie, K. L.
    Young, L. H.
    Inzucchi, S. E.
    Gorman, M.
    Guarino, P. D.
    Lovejoy, A. M.
    Peduzzi, P. N.
    Conwit, R.
    Brass, L. M.
    Schwartz, G. G.
    Adams, H. P., Jr.
    Berger, L.
    Carolei, A.
    Clark, W.
    Coull, B.
    Ford, G. A.
    Kleindorfer, D.
    O'Leary, J. R.
    Parsons, M. W.
    Ringleb, P.
    Sen, S.
    Spence, J. D.
    Tanne, D.
    Wang, D.
    Winder, T. R.
    NEW ENGLAND JOURNAL OF MEDICINE, 2016, 374 (14): : 1321 - 1331
  • [47] Ultra-early intravenous thrombolytic therapy for recurrent ischemic stroke after transient ischemic attack
    Kobayashi, Junpei
    Ohara, Tomoyuki
    Sato, Kazuaki
    Uehara, Toshiyuki
    Minematsu, Kazuo
    Toyoda, Kazunori
    NEUROLOGY AND CLINICAL NEUROSCIENCE, 2014, 2 (03): : 84 - 86
  • [48] Transient ischemic attack an stroke associated with sildenafil (Viagra) use - Reply
    Morgan, JC
    Johnston, KC
    NEUROLOGY, 2002, 59 (02) : 293 - 294
  • [49] Determination of lipid profiles and use of statins in patients with ischemic stroke or transient ischemic attack
    Lalouschek, W
    Lang, W
    Greisenegger, S
    Müllner, M
    STROKE, 2003, 34 (01) : 105 - 110
  • [50] Pioglitazone after Ischemic Stroke or Transient Ischemic Attack
    Bursztyn, Michael
    NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (07): : 702 - 703